TwitterRSSFacebookDirectors Blog
  Disorders A - Z:   A    B   C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z

Skip secondary menu

NINDS Small Research Grant (R03) Program Guidelines


Application Receipt Dates: February 16, June 16, October 16


NIH Program Announcement

The National Institute of Neurological Disorders and Stroke (NINDS) participates in the NIH Small Research Grant Program (PA-03-108). Applicants must follow instructions in the parent program announcement when preparing an application. In addition, applicants to the NINDS Small Research Grant Program must be responsive to the "Guidelines for the NINDS R03 Program" (below).

NIH Small Research Grant Program (R03): http://grants.nih.gov/grants/guide/pa-files/PA-10-064.html

Guidelines for the NINDS R03 Program

The NINDS uses the Small Grants Program (R03) to provide research support for new research projects in areas of high relevance to the mission of the NINDS. Applicants may request a project period of up to two years and a budget for direct costs of up to two $25,000 modules or $50,000 per year may be requested (see also full program announcement). Priority will be given to applications in any of the following categories:

  1. Research projects leading to a defined product, resource or "deliverable" that has inherent value to the neuroscience community. Some examples include: creation of new animal models (e.g., mouse genetic models), generation of reagents (e.g., antibodies, RNAi, affinity capture reagents for use in a protein chip microarray), development of public resources (e.g., databases), development of cellular models for neurological disorders, development of novel phenotypic or behavioral screens for models of neurological disorders.

  2. Research projects that, regardless of whether they are hypothesis-driven, will generate an important and potentially publishable unit of information or dataset (either by itself or in combination with other data). Such projects should utilize a well-designed model of the normal or diseased nervous system. Some examples include: microarray gene expression analyses, proteomic analyses, pre-clinical drug screens.

  3. Research projects focused on secondary analysis of clinical data sets. This mechanism could also be appropriate for the collection of samples and/or associated clinical data to be included in the NINDS Genetics Repository (see: http://locus.umdnj.edu/ninds/).

Priority will be given to research proposals that include a detailed plan for the sharing of resources and data generated under this award. Potential applicants are strongly advised to contact program staff to verify that the proposed research is relevant to NINDS and responsive to one of the listed criteria. A complete listing of program director contacts may be found at: http://www.ninds.nih.gov/about_ninds/organization.htm

General inquiries may be referred to:

Chief, Scientific Review Branch,
Division of Extramural Research, NINDS, NIH
NSC Building, Room 3208, MSC 9529
6001 Executive Blvd.
Bethesda, Maryland 20852
(301) 496-9223
FAX: (301) 402-0182
nindsreview@mail.nih.gov

Last updated March 27, 2012